← FDA DRUG APPROVALS

FDA ANDA · ANDA060521

HUMATIN

Sponsor: PARKEDALE

APPLICATION
ANDA060521
TYPE
ANDA
ORIGINAL APPROVAL
1969-03-24
LATEST ACTION
1969-03-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

HUMATINDiscontinued
PAROMOMYCIN SULFATE EQ 250MG BASE · CAPSULE · ORAL

Approval history

1969-03-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →